Corrigendum to “Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy” [Euro. J. Med. Chem. (2024) 116765]

IF 5.9 2区 医学 Q1 CHEMISTRY, MEDICINAL European Journal of Medicinal Chemistry Pub Date : 2025-01-26 DOI:10.1016/j.ejmech.2025.117307
Hualong Mo , JieYing Liu , Zhengxi Su , Deng-Gao Zhao , Yan-Yan Ma , Kun Zhang , Qi Wang , Chun Fu , Yao Wang , Meiwan Chen , Burong Hu
{"title":"Corrigendum to “Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy” [Euro. J. Med. Chem. (2024) 116765]","authors":"Hualong Mo , JieYing Liu , Zhengxi Su , Deng-Gao Zhao , Yan-Yan Ma , Kun Zhang , Qi Wang , Chun Fu , Yao Wang , Meiwan Chen , Burong Hu","doi":"10.1016/j.ejmech.2025.117307","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"286 ","pages":"Article 117307"},"PeriodicalIF":5.9000,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425000728","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
“异丙酸内酯/羟肟酸混合物作为有效的双重STAT3/HDAC抑制剂和自组装纳米颗粒用于癌症治疗”的勘误表[欧洲]。医学化学。(2024) 116765)
作者遗憾地通知,在图9中,对照组和18 (2.5 mg/kg)组使用了相同的TUNEL染色图像。我们已经用正确的图像替换了它。下面列出了正确的表格。下载:下载高分辨率图片(2MB)下载:下载全尺寸图片9. PBS、SAHA、18、18 NPs处理后肿瘤组织的H&;E染色和TUNEL染色分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
期刊最新文献
Dual-action mitochondria-targeted prodrugs that both deplete mitochondrial glutathione and deliver a toxic payload to the matrix Design and Optimization of Potent, Selective, and Peripherally Acting JNK3 Inhibitors for Chronic Kidney Disease Characteristics of Osteoclasts at Different Developmental Stages and Therapeutic Strategies Structure-activity relationship profiling of N-substituted 8-trifluoromethyl-9H-purin-6-amines as mitochondrial protonophores Multi-Target-Directed Chromone–Carboxamide Hybrids: Potent AChE/MAO-B Inhibitors with Anti-Aβ/Tau and Neuroprotective Activities
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1